Skip to main content
logo
Nurix Therapeutics, Inc. (NRIX)
NASDAQ: NRIX · Real-Time Price · USD
26.23
+0.27 (1.04%)
Aug 12, 2026, 11:56 AM EDT - Market open

Nurix Therapeutics Financials Overview

Millions USD. Fiscal year is Dec - Nov.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMay '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Revenue
36.7783.9854.5576.9938.6329.75
Revenue Growth
-58.40%53.95%-29.14%99.31%29.84%66.95%
Gross Profit
36.7783.9854.5576.9938.6329.75
Operating Income
-361.18-285.67-213.03-155.06-183.87-117.89
Net Income
-341.35-264.46-193.57-143.95-180.36-117.19
Earnings Per Share
-3.45-3.05-2.88-2.65-3.71-2.73
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMay '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Cash & Investments
443.53592.94609.58287.91309.14295.72
Total Debt
58.1455.7328.330.6111.9613.04
Net Cash (Debt)
385.39537.21581.28257.29297.18282.68
Net Cash Growth
-11.17%-7.58%125.92%-13.42%5.13%0.55%
Net Cash Per Share
3.856.208.664.746.116.59

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMay '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Operating Cash Flow
-57.39-249.47-172.87-81.08-159.81-84.37
Capital Expenditures
-2.71-14-9.27-8.4-12.24-5.66
Free Cash Flow
-60.1-263.47-182.14-89.48-172.05-90.03
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMay '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-982.37%-340.16%-390.52%-201.41%-476.01%-396.25%
Pretax Margin
-929.18%-314.00%-354.36%-186.98%-466.93%-393.49%
Profit Margin
-928.44%-314.90%-354.85%-186.98%-466.93%-393.93%
FCF Margin
-163.45%-313.73%-333.91%-116.23%-445.42%-302.61%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Nov '25 Nov '24 Nov '23 Nov '22 Nov '21
PS Ratio
73.2821.4330.753.9415.1343.27